Tapolczay David
SEC insider (Form 3/4/5 filer). CIK 0001991789. Chief Executive Officer at CONDUIT PHARMACEUTICALS INC. (CDT). 1 reported Form 4/5 transaction since Sep 2024; latest on Nov 18, 2024. Located in NAPLES, FL.
Companies Tapolczay David has filed insider reports for
- CONDUIT PHARMACEUTICALS INC. (CDT): Director, Officer, Chief Executive Officer
Tapolczay David
CIK: 0001991789
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CDT
CONDUIT PHARMACEUTICALS INC.
DirectorOfficer